Uncategorized

Fasola is the second-highest paid executive at the insurer, trailing only CEO Sarah London.

Contar con un seguro médico familiar es una opción cada vez más demandada para cuidar de la salud de nuestros seres queridos. Es por eso, que este tipo de póliza ofrece una cobertura integral para todos los miembros de la familia, facilitando el acceso a servicios m&eacut …

Saum Sutaria doesn’t think the ACA marketplace is going anywhere under President-elect Donald Trump, noting beneficiaries are an “important part of the electorate” for the incoming administration.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology in the Twiist device.

The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the long-term success of our core consumer business.”

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a continued appetite for these drugs.

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals after-the-fact rebates for two drugs in the 340B drug discount program, instead of offering upfront discounts.

Following patient deaths in a lupus trial that led to the termination of that program, Kezar’s autoimmune candidate zetomipzomib faces a partial clinical hold barring four trial participants from continuing treatment in the open-label portion of the trial, though the trial itself will continue as planned.

Leerink analysts said the results were largely in line with outcomes in a trial of Inspire Medical’s rival device but cautioned that Livanova may have a hard time breaking into the sleep apnea market.

Medical groups’ median investment per employed physician reached $304,312 in the third quarter, the first time the metric has risen above $300,000, according to Kaufman Hall.